Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN002017 | 54.01 | 6.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 54.01 | 6.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 54.01 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 58.06 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 58.06 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.05 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.08 | 4.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.08 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Urea | 61.0398 | 2.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 61.04 | 2.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.04 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.04 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 7.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 72.08 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 74.06 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Isobutylamine | 74.0954 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 74.1 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 74.1 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 75.1 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glycine | 76.0383 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Trimethylamine N-oxide | 76.0752 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 79.02 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 80.05 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 80.05 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 83.06 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.04 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.04 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.08 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.96 | 9.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-TMAO iSTD | 85.1319 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 86.06 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.06 | 2.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.07 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 6.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.07 | 1.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 4.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 89.06 | 1.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | beta-Alanine | 90.0539 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 90.98 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 91.07 | 2.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 93.06 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-DL-Alanine iSTD | 93.0728 | 7.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Picoline | 94.0646 | 4.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 2-Aminopyridine | 95.0594 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 96.04 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 1.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Pyridone | 96.0446 | 2.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 100.07 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 101.11 | 3.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 101.11 | 3.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 2.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 2.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.05 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.13 | 3.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.79 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 104.11 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 104.11 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Serine | 106.0486 | 8.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylaniline | 108.0791 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 108.08 | 3.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 108.08 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 108.08 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.07 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.07 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-.alpha.-(tert-Butoxycarbonyl)-L-histidine | 110.0702 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 112 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112 | 9.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112.01 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112.05 | 6.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 113.03 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 113.07 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Choline iSTD | 113.1634 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 113.72 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 114.06 | 3.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Creatinine | 114.0662 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 115.05 | 3.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.09 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.09 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Proline | 116.0694 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 116.07 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.07 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.07 | 13.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.12 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.14 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ketoisovaleric acid | 117.0534 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 117.07 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Creatinine iSTD | 117.0847 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 117.73 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Betaine | 118.0862 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 118.09 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 118.09 | 7.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 119.1 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 120.06 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Homoserine | 120.0639 | 8.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Threonine | 120.0642 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 120.08 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 120.1 | 5.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.07 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.09 | 2.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.09 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.1 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.92 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 123.05 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Nicotinic acid | 124.0384 | 4.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 124.92 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 125.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 125.98 | 9.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.02 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Taurine | 126.0212 | 7.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 126.09 | 1.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.09 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 127.07 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 127.07 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Betaine iSTD | 127.1424 | 6.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Dihydro-4,4-dimethyl-2,3-furandione | 129.0531 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 129.07 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Histamine, N-methyl- iSTD | 129.1202 | 7.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 129.14 | 1.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyroglutamic acid | 130.0488 | 8.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 130.05 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.06 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.08 | 6.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylproline | 130.085 | 6.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Pipecolic acid | 130.0855 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 130.09 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.09 | 8.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.09 | 9.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.1 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.05 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 6.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.68 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Hydroxyproline | 132.0632 | 7.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 132.07 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 5.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.1 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.1 | 7.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Isoleucine | 132.101 | 6.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Norleucine | 132.1012 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 133.09 | 7.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ornithine | 133.0957 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Aspartic acid | 134.0432 | 8.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxybenzylcyanide | 134.0591 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 6-Aminoindazole | 134.0697 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 134.09 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 134.12 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Creatine iSTD | 135.0951 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 136.04 | 1.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 1.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 2.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.05 | 4.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.05 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.06 | 2.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Adenine | 136.0603 | 4.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 136.07 | 7.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 137.04 | 4.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 137.04 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hypoxanthine | 137.0452 | 4.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D3-DL-Aspartic acid iSTD | 137.0625 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 138.05 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 138.05 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 138.05 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Aminobenzoic acid | 138.0536 | 7.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Imidazoleacrylic acid | 139.0487 | 3.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Urocanic acid | 139.0502 | 3.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 140.05 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Deferiprone | 140.0692 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 140.07 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.08 | 4.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.08 | 4.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-1-Methylnicotinamide iSTD | 140.0895 | 6.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 141.06 | 7.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.02 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.08 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.08 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.08 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.12 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Methyl-5-thiazoleethanol? | 144.0463 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 144.1 | 6.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.1 | 7.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.1 | 13.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N.alpha.-Methyl-L-lysine | 144.1005 | 6.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 144.17 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.17 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.17 | 1.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.05 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.1 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.1 | 7.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ethylhexanoate | 145.1208 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 145.13 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.02 | 4.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.06 | 6.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Acetamidobutyric acid | 146.0799 | 2.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 146.08 | 2.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Guanidinobutyric acid | 146.0897 | 7.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylisoleucine | 146.1161 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | (3-Carboxypropyl)trimethylammonium | 146.1162 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 146.12 | 2.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.12 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutamine | 147.0758 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 147.11 | 8.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 147.11 | 8.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Lysine | 147.112 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Trimethylammoniobutanoic acid | 147.1197 | 7.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 148 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 148 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutamic acid | 148.0592 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | (+)-Pseudoephedrine | 148.1114 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxy-3-methoxymandelic acid | 149.0222 | 0.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Dihydrocoumarin | 149.0576 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxymandelonitrile | 150.0566 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Methionine | 150.0573 | 7.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 150.1 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 150.14 | 2.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.05 | 8.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-DL-Glutamic acid iSTD | 151.0785 | 8.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 151.09 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 4.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 4.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Guanine | 152.0553 | 6.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Acetaminophen | 152.0689 | 1.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D5-L-Glutamine iSTD | 152.107 | 8.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 153.06 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Crotonobetaine iSTD | 153.1583 | 7.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Creatine | 154.057 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 154.12 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.04 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.04 | 8.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Butyrobetaine iSTD | 155.1739 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 156.04 | 6.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 2.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Histidine | 156.0756 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 156.08 | 8.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.08 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.08 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.1 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.1 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.08 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.08 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.1 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.17 | 1.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 158.12 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 158.96 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.06 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.07 | 4.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.08 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.08 | 4.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.15 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.15 | 8.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.03 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.03 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.04 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.07 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Betonicine | 160.0955 | 7.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 160.13 | 5.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.13 | 6.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.13 | 6.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.2 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.06 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methyllysine | 161.1273 | 9.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 161.13 | 7.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.62 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.62 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylglutamic acid | 162.0744 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 162.1 | 2.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Carnitine | 162.112 | 7.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 163.12 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 164.03 | 7.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.01 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.05 | 7.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.11 | 2.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.11 | 2.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-L-Carnitine iSTD | 165.131 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Methioninesulfoxide A | 166.0516 | 8.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 166.07 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylalanine | 166.0862 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 166.09 | 6.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 167.08 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Carbamic acid, N-(2,2-diphenylacetyl)-, ethyl ester | 167.0847 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 168.06 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyridoxal | 168.0641 | 1.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Vanillic acid | 169.057 | 8.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 169.06 | 8.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.17 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.19 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.98 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyridoxine | 170.0796 | 3.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 170.08 | 3.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 6.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 9.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 9.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Methylhistidine | 170.0918 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylhistidine | 170.0924 | 8.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 170.12 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.12 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 171.07 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 172.13 | 7.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.07 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.08 | 5.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.08 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.09 | 7.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.01 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.11 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.11 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.03 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.03 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.1 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.11 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.11 | 8.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Arginine | 175.1187 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 175.14 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 176.09 | 7.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Citrulline | 176.1017 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 177.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 177.09 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 177.09 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Serotonin | 177.1004 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 15N2-L-Arginine iSTD | 177.1114 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 178.08 | 6.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.08 | 6.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.08 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 2.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 3.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 3.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.05 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | trans-Nicotine-1'-oxide | 179.1164 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 179.12 | 1.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 6.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.13 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hippuric acid | 180.0636 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Galactosamine | 180.0865 | 8.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | beta-Homophenylalanine | 180.0998 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 180.1 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.1 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylphenylalanine | 180.1003 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 181.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 181.05 | 4.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Theobromine | 181.0705 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Paraxanthine | 181.0705 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 182.06 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tyrosine | 182.0795 | 7.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 182.08 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.08 | 1.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.1 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.96 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 183.18 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.05 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Pyridoxate | 184.059 | 2.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 184.07 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3,5-Dihydroxyphenylglycine | 184.0703 | 8.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Phosphocholine | 184.0718 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 184.09 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.09 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.1 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.08 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.09 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.09 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.1 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.12 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.13 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.13 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 186.11 | 6.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ecgonine | 186.1111 | 7.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 186.15 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 186.22 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 8.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 9.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 9.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.1 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.11 | 7.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.13 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.07 | 5.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.08 | 4.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 7.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 7.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.17 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N8-Acetylspermidine | 188.1744 | 8.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 189.07 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.07 | 4.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.07 | 4.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-epsilon-Acetyllysine | 189.122 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Gly-Leu | 189.1222 | 7.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Homoarginine | 189.1331 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-trimethyllysine | 189.1586 | 8.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 3-Indolepropionic acid | 190.085 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 191.04 | 8.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2,6-Diaminopimelic acid | 191.1021 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 192.08 | 3.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.09 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.09 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.1 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.12 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.1 | 2.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tocainide | 193.1415 | 4.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Phenylacetylglycine | 194.0817 | 2.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 194.1 | 7.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 194.1 | 7.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Caffeine | 195.0863 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 195.1 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 195.12 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 196.06 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 196.06 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Deoxy-1-(methylamino)-D-galactitol | 196.1167 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 3-Aminotyrosine | 197.088 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 197.2 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 198.07 | 4.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetylhistidine | 198.085 | 7.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 198.09 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 198.09 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.07 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.14 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.17 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.17 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 200.13 | 6.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 201.98 | 7.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 202.07 | 8.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 202.11 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 8.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ser-Pro | 203.1124 | 8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Ala-Ile | 203.1379 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N,N-Dimethylarginine | 203.1494 | 8.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 203.15 | 8.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.5 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Acetyl-L-carnitine | 204.1213 | 12.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Acetylcarnitine | 204.123 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D9-Caffeine iSTD | 204.1438 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 205.09 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tryptophan | 205.0958 | 6.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 206.05 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.14 | 6.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.89 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-AC(2:0) iSTD | 207.1417 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 207.21 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.01 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.01 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.88 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Kynurenine | 209.0904 | 6.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 209.2 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.01 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.1 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.1 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.11 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.12 | 5.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pro-Pro | 213.1211 | 7.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 214.92 | 10.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 215.07 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Chlorotyrosine | 216.0402 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 216.06 | 8.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 216.12 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 216.91 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Diphenylmethylphosphine oxide | 217.0759 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.08 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 6-Methoxynaphthaleneacetic acid | 217.0852 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.1 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-.alpha.-Acetyl-L-arginine | 217.128 | 7.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.18 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 217.18 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 218.1 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Propionylcarnitine | 218.1386 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 218.91 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 219.1 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 219.1 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetyl-5-hydroxytryptamine | 219.1126 | 3.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Pantothenic acid | 220.1173 | 3.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 220.12 | 3.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 220.12 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.07 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.17 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.17 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.99 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.99 | 9.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 225.03 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.04 | 7.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.04 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.95 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.08 | 2.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.08 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.11 | 4.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.21 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.02 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.03 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2'-Deoxycytidine | 228.0965 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 229.08 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Deoxyuridine | 229.084 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 229.11 | 4.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.11 | 4.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ergothioneine | 230.0939 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 230.25 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 231.09 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Naproxen | 231.101 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 231.12 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 3.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 5.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 6.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.09 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | (R)-Butyrylcarnitine | 232.1542 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 232.93 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.06 | 8.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.08 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.09 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.09 | 1.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 234.11 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.17 | 1.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.18 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 236.07 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 239.06 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Gly-Tyr | 239.1043 | 7.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 240.1 | 5.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.15 | 1.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.16 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.86 | 13.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cystine | 241.0296 | 9.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 241.1 | 2.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | cis-lambda-Viniferin | 241.1781 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 241.18 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.18 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.19 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.23 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.1 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.1 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.64 | 9.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cytidine | 244.092 | 6.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 244.13 | 8.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.15 | 5.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.22 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.07 | 7.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pseudouridine | 245.0749 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Biotin | 245.0974 | 2.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 245.1 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.1 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.14 | 3.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.15 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Methylbutyryl-L-carnitine | 246.1693 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 246.18 | 9.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.18 | 9.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.15 | 5.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.11 | 8.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.13 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.13 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Hydroxybutyrylcarnitine | 248.1487 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 248.15 | 5.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.15 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 249.11 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 249.18 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.09 | 2.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.09 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.13 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.2 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.21 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.03 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.08 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.11 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.12 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 1.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.15 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 253.12 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 253.13 | 6.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Sulfamethoxazole | 254.058 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 254.14 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 254.14 | 1.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.04 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.21 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.94 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 256.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 257.15 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 257.32 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 258.07 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2'-O-Methylcytidine | 258.1068 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 258.2 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 259.19 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 259.19 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 260.15 | 6.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hexanoyl-L-carnitine | 260.1845 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 261.1 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma-Glutamylleucine | 261.1431 | 7.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 261.15 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.2 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.21 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.21 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 262.14 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Asp-Glu | 263.0859 | 9.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 263.17 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 264.19 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 265.11 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 265.11 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylacetylglutamine | 265.119 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 266.16 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.16 | 7.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.17 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.2 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.07 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.08 | 2.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.19 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 268.1 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 8-Oxo-2-deoxyadenosine | 268.1034 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Adenosine | 268.1045 | 4.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 268.26 | 4.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 268.26 | 4.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Inosine | 269.0868 | 6.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Acetyl-L-carnosine | 269.123 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 269.2 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 273.12 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 273.17 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.01 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.27 | 1.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.27 | 1.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 275.16 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma-Glutamylglutamine | 276.1178 | 9.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 276.18 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma.-Glutamyl-L-glutamic acid | 277.1013 | 9.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 277.18 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.19 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.21 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.21 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 278.16 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.09 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.69 | 8.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 280.15 | 5.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Linoleic acid | 281.2459 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 281.25 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.05 | 6.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Methyladenosine B | 282.1189 | 7.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 282.14 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.18 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.28 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 283.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3'-O-Methylinosine | 283.1049 | 4.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 283.19 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 284.33 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 285.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 285.13 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Piperine | 286.1422 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 286.2 | 4.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Heptadecasphing-4-enine | 286.2729 | 4.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 287.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylacetyl-L-glutamine | 287.0996 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 287.21 | 4.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.15 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.21 | 3.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.22 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.22 | 4.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 289.24 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 290.85 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Trimethoprim | 291.1436 | 4.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 291.18 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.18 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.23 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.23 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.25 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.97 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 292.2 | 9.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 292.84 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 9.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.11 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.14 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.22 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.1 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.11 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.84 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.94 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.06 | 4.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.06 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.07 | 4.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.1 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.22 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.22 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.23 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.23 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 296.01 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 296.01 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetylsulfamethoxazole | 296.0682 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 296.22 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.08 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.15 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.15 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.24 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.24 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 298.02 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cysteine-glutathione disulfide | 298.051 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 5'-S-Methyl-5'-thioadenosine | 298.0974 | 1.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 298.1 | 1.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 298.1 | 1.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Methylguanosine | 298.1131 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 298.18 | 8.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ethylhexadecyldimethylammonium cation | 298.3451 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 299.14 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 299.26 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.09 | 1.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.25 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.25 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 301.12 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Desmethylranitidine | 301.1313 | 5.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 301.15 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Retinoic acid | 301.2142 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 303.19 | 6.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.21 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.21 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.3 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 305.96 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 307.03 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 307.17 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutathione (reduced) | 308.0907 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 308.15 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 308.21 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Dihydrocapsaicin | 308.2183 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 308.28 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.05 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.12 | 2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.15 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.99 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.02 | 9.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 4.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.31 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N2,N2-Dimethylguanosine | 312.1286 | 5.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 313.14 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.16 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.23 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.07 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.1 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.18 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.08 | 10.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.08 | 10.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.1 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.12 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.13 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.13 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ranitidine | 315.1487 | 4.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 315.15 | 4.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.19 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Octadecanedioic acid | 315.2516 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 316.07 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.25 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 8.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 9.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 9.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 10.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 13.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 13.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 8.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.19 | 1.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
